They resent the fact that some people got special treatment, when they had to suffer through losing their jobs, losing their homes to short sals and foreclosures, and seeing the world as they knew it before 2008 disappear.
Pfizer and its partner, Protalix BioTherapeutics, just gotsome good news from the Food and Drug Administration: Elelyso, a treatment for a rare genetic disorder called Gaucher disease, was approved.